Rachel Tsunemoto Hislop, PhD
InvestorPrincipal, Director of Research at Two Bear Capital
San Diego, California, United States
Writes $3M – $10M checks
About
Rachel Tsunemoto Hislop pairs UC San Diego stem-cell and developmental neurobiology research and Acorda medical affairs experience with leading San Diego research team that produces formal, data-driven insights across research-to-commercialization
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechCybersecurityEnterprise SoftwareHealthtech
Experience
- Two Bear CapitalPrincipal, Director of Researchcurrent2024 — present
- Two Bear CapitalPrincipal2020 — 2024
- Abilita Therapeutics, Inc.Board Observer2022 — 2024San Diego, California, United States
- Novoron BioscienceBoard Observer2021 — 2024San Diego, California, United States
- Acorda Therapeutics, Inc.Medical Science Liaison2017 — 2020
- UC San Diego HealthStem Cell and Molecular Biology Researcher2016 — 2017Greater San Diego Area
- FreelanceScience Communicator2013 — 2016Greater San Diego Area
- UC San DiegoNeuroscience Ph.D. Candidate and Research Associate2010 — 2016Greater San Diego Area
- MITUndergraduate Research Assistant2008 — 2009Greater Boston Area
- Merck (Neuroscience Drug Discovery Department)Summer Research Intern2007Greater Boston Area
Colleagues at Two Bear Capital
Amalia Colangelo
Principal at Two Bear Capital
Ashley Archibeque
Executive Assistant at Two Bear Capital
Avery Sonnenberg
Principal at Two Bear Capital
Bria Iuliano
Executive Assistant at Two Bear Capital
Bridget Martell MA, MD
Senior Biopharmaceutical Advisor at Two Bear Capital
Cris Neckar
Partner at Two Bear Capital
Ellen Lubman
Biopharmaceutical Advisor at Two Bear Capital
Ellen Lubman, MBA
Biopharmaceutical Advisor at Two Bear Capital
Frequently asked questions
- Who is Rachel Tsunemoto Hislop, PhD?
- Rachel Tsunemoto Hislop pairs UC San Diego stem-cell and developmental neurobiology research and Acorda medical affairs experience with leading San Diego research team that produces formal, data-driven insights across research-to-commercialization
- Where does Rachel Tsunemoto Hislop, PhD work?
- Rachel Tsunemoto Hislop, PhD is Principal, Director of Research at Two Bear Capital.
- What does Rachel Tsunemoto Hislop, PhD invest in?
- Rachel Tsunemoto Hislop, PhD invests in AI & Machine Learning, Biotech, Cybersecurity, Enterprise Software, Healthtech.
- What check size does Rachel Tsunemoto Hislop, PhD write?
- Rachel Tsunemoto Hislop, PhD typically writes checks of $3M – $10M.
- Where did Rachel Tsunemoto Hislop, PhD go to school?
- Rachel Tsunemoto Hislop, PhD studied at Massachusetts Institute of Technology (Bachelor of Science (B.S.), Brain and Cognitive Studies); UC San Diego (Doctor of Philosophy (Ph.D.), Neuroscience).
Same school
Also attended Massachusetts Institute of Technology1,387
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and Techstars
+ 1,381 more
Also attended UC San Diego307
Elad GilSolo general partner investing through Gil CapitalMark SusterManaging Partner at Upfront VenturesChester NgGeneral Partner at AtomicBirgitteInvestor at InvestinorHouman HaghighiPartner, Business & Corporate Development at Menlo VenturesFreya Svedberg-KeatingInvestor at Medicxi
+ 301 more
Shared employers
Also worked at Two Bear Capital27
Ashley ArchibequeExecutive Assistant at Two Bear CapitalErika BoldenOperations Manager at Two Bear CapitalKevin DayPartner, Head of Capital Formation at Two Bear CapitalMeagan HennigPartner, Head of Operations at Two Bear CapitalJennifer HowriganVP, Investor Relations at Two Bear CapitalBria IulianoExecutive Assistant at Two Bear Capital
+ 21 more
